Magnesium lithospermate B ameliorates renal cortical microperfusion in rats

Acta Pharmacologica Sinica

Volumn 27, Issue 2, 2006, Pages 217-222

  Chen, Chun Guang ^a,b   Wang, Yi Ping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Hemodynamics; Magnesium lithospermate B; Renal blood flow; Renal cortical microperfusion

Indexed keywords

MAGNESIUM LITHOSPERMATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY CORTEX; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RENAL PROTECTION; SALVIA MILTIORRHIZA;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HEART RATE; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENOUS; KIDNEY CORTEX; MALE; MICROCIRCULATION; PLANTS, MEDICINAL; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SALVIA MILTIORRHIZA; VASCULAR RESISTANCE;

EID: 31644447525     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00225.x     Document Type: Article

References (41)

1. Yokozawa T, Chung HY, Oura H, Nonaka G, Nishioka I. Isolation of the active component having the uremia-preventive effect from Salviae miltiorrhizae radix extract. Chem Pharm Bull (Tokyo) 1988; 36: 316-20.
2. Yokozawa T, Chung HY, Oura H, Nonaka G, Nishioka I. Effect of (Dihydro) caffeic acid tetramer isolated from Salviae miltiorrhizae. J Med Pharm Soc for Wakan-Yaku 1988; 5: 163-6.
3. Yokozawa T, Chung HY, Lee TW, Oura H, Tanaka T, Nonaka G et al. Contribution of prostaglandins to the renal responses to magnesium lithospermate B isolated from Salviae miltiorrhizae radix. Chem Pharm Bull (Tokyo) 1989; 37: 1568-71.
4. Yokozawa T, Chung HY, Lee TW, Oura H, Tanaka T, Nonaka G, et al. Effect of magnesium lithospermate B on urinary excretion of arachidonate metabolites in rats with renal failure. Chem Pharm Bull (Tokyo) 1989; 37: 2766-9.
5. Yokozawa T, Chung HY, Oura H, Nonaka G, Nishioka I. Isolation of a renal function-facilitating constituent from the oriental drug, Salviae miltiorrhizae radix. J Nephrol 1989; 31: 1091-8.
6. Yokozawa T, Lee TW, Chung HY, Oura H, Nonaka G, Nishioka I. Effect of magnesium lithospermate B on urinary prostaglandins in rats with renal failure. J Nat Prod 1990; 53: 662-5.
7. Yokozawa T, Chung HY, Lee TW, Oura H, Nonaka G, Nishioka I. Magnesium lithospermate B improves renal function via the kallikrein-prostaglandin system in rats with renal failure. J Nephrol 1990; 32: 893-8.
8. Yokozawa T, Lee TW, Chung HY, Oura H, Nonaka G, Nishioka I. Renal response to magnesium lithospermate B. J Pharm Pharmacol 1990; 42: 712-5.
9. Yokozawa T, Oura H, Lee TW, Nonaka G, Nishioka I. Augmentation of renal response by magnesium lithospermate B. Nephron 1991; 57: 78-83.
10. Yokozawa T, Lee TW, Oura H, Nonaka G, Nishioka I. Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 1992; 60: 460-5.
11. Yokozawa T, Dong E, Liu ZW, Shibata T, Hasegawa M, Watanabe H, et al. Magnesium lithospermate B ameliorates cephaloridine-induced renal injury. Exp Toxicol Pathol 1997; 49: 337-41.
12. Yokozawa T, Dong E, Oura H, Kashiwagi H, Nonaka G, Nishioka I. Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 1997; 75: 88-93.
13. Yokozawa T, Lee TW, Oura H, Nonaka G, Nishioka I, Hattori M. Effect of magnesium lithospermate B on the renal and urinary kallikrein activities in rats with adenine induced renal failure. Nippon Jinzo Gakkai Shi 1993; 35: 337-42.
14. Lee GT, Ha H, Jung M, Hong SW, Cha BS, Lee HC, et al. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol 2003; 14: 709-20.
15. Kang DG, Oh H, Sohn EJ, Hur TY, Lee KC, Kim KJ, et al. Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats. Life Sci 2004; 75: 1801-6.
16. Wu XJ, Wang YP, Wang W, Sun WK, Xu YM, Xuan LJ. Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol Sin 2000; 21: 855-8.
17. Soung do Y, Rhee SH, Kim JS, Lee JY, Yang HS, Choi JS, et al. Peroxynitrite scavenging activity of lithospermate B from Salvia miltiorrhiza. J Pharm Pharmacol 2003; 55: 1427-32.
18. Heyman SN, Fuchs S, Jaffe R, Shina A, Ellezian L, Brezis M, et al. Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: effect of saline infusion, indomethacin and radiocontrast. Kidney Int 1997; 51: 653-63.
19. Lien B, Norstein J, Salerud EG, Kvernebo K, Flatmark A. Renal microvascular perfusion evaluated by single fibre laser Doppler flowmetry. Int J Microcirc Clin Exp 1992; 11: 307-17.
20. Yokozawa T, Lee TW, Oura H, Zhang XY, Hattori M, Nonaka G, et al. Haemodynamic effect of magnesium lithospermate B in rats with renal failure. Phytother Res 1992; 6: 194-9.
21. Li XC, Yu C, Sun WK, Liu GY, Jia JY, Wang YP. Pharmacokinetics of magnesium lithospermate B after intravenous administration in beagle dogs. Acta Pharmacol Sin 2004; 25: 1402-7.
22. - and NO. Am J Physiol Renal Physiol 2000; 279: F302-8.
23. Wilcox CS, Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand 2000; 168: 119-24.
24. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 2001; 37: 547-53.
25. Ozawa Y, Hayashi K, Wakino S, Kanda T, Homma K, Takamatsu I, et al. Free radical activity depends on underlying vasoconstrictors in renal microcirculation. Clin Exp Hypertens 2004; 26: 219-29.
26. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32: 59-64.
27. - and NO. Am J Physiol Renal Physiol 2000; 279: F302-8.
28. Schoonmaker GC, Fallet RW, Carmines PK. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus. Am J Physiol Renal Physiol 2000; 278: F302-9.
29. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 2002; 282: R335-42.
30. Tylicki L, Rutkowski B, Horl WH. Antioxidants: A possible role in kidney protection. Kidney Blood Press Res 2003; 26: 303-14.
31. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004; 13: 93-9.
32. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1-80.
33. Hornig D, Drexler H. Endothelial function and bradykinin in humans. Drugs 1997; 54: 42-7.
34. Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol Renal Physiol 1987; 253: F377-87.
35. Baer PG, McGiff JC. Comparison of effects of prostaglandins E2 and 12 on rat renal vascular resistance. Eur J Pharmacol 1979; 54: 359-63.
36. Inscho EW, Carmines PK, Navar LG. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Physiol Renal Physiol 1990; 259: F157-63.
37. Arendshorst WJ, Beierwaltes WH. Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol Renal Physiol 1979; 236: F246-51.
38. Folkow B, Gothberg G, Ludin S. Structural "resetting" of the renal vascular bed in spontaneously hypertensive rats. Acta Physiol Scand 1977; 199: 270-2.
39. Chatziantoniou C, Arendshorst WJ. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am J Physiol Renal Physiol 1992; 262: F68-76.
40. Jackson EK, Heidemann HT, Branch RA, Gerkens JF. Low dose intrarenal infusions of PGE 2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney. Circ Res 1982; 51: 67-72.
41. Lonigro AJ, Terragno NA, Malik KU, McGiff JC. Differential inhibition by prostaglandins of the renal actions of presser stimuli. Prostaglandins 1973; 3: 595-606.